Results 31 to 40 of about 29,663 (265)

The vaccine coverage and vaccine immunity status and risk factors of non-protective levels of antibodies against vaccines in children with juvenile idiopathic arthritis: cross-sectional Russian tertiary Centre study

Pediatric Rheumatology Online Journal, 2021
Background Immunosuppressive drugs, incomplete vaccine coverage, immune system dysregulation might be factors of a low level of anti-vaccine antibodies in JIA patients. The study aimed to evaluate vaccine coverage, post-vaccine immunity, and risk factors
Mikhail M. Kostik, Natalia A. Lubimova, Irina V. Fridman, Olga V. Goleva, Susanna M. Kharit   +4 more
doaj   +1 more source

The reform of the Italian legislation on childhood immunization [PDF]

, 2018
Upon the proposal of the Italian government, Law n. 191/2017 has been enacted, meant to considerably raise the number of mandatory vaccinations, while leaving several others merely "recommended" (non-mandatory).
Cocchiara, Rosario Andrea, La Torre, Giuseppe, Marinelli, Enrico, Montanari Vergallo, Gianluca, Zaami, Simona   +4 more
core   +1 more source

Immunogenicity and safety of the new MMR vaccine containing measles AIK-C, rubella Takahashi, and mumps RIT4385 strains in Japanese children: a randomized phase I/II clinical trial

Human Vaccines & Immunotherapeutics, 2019
Domestic measles, mumps, and rubella combined (MMR) vaccines were discontinued in 1993 in Japan because of the unexpected high incidence of aseptic meningitis. The introduction of an effective MMR vaccine with lower reactogenicity has been expected.
Tetsuo Nakayama, Masahiro Eda, Motonori Hirano, Wakako Goto   +3 more
doaj   +1 more source

Immunogenicity and Safety of a Novel MMR Vaccine (Live) (Freeze-dried): Results of a Phase II Clinical Trial [PDF]

Journal of Clinical and Diagnostic Research, 2018
Introduction: This is the first study in Indian paediatric subjects to evaluate the novel Measles, Mumps and Rubella (MMR) vaccine developed by M/s Cadila Healthcare Limited, India, containing the Hoshino mumps strain.
Rajesh Joshi, Neeta Hanumante, Uma Nayak, Shalaka Agarkhedkar, Paresh Thakkar, Jayesh Sanmukhani, Ravindra Mittal   +6 more
doaj   +1 more source

The efficacy of 20% salicylic acid solution versus intralesional MMR vaccine combination with 20% salicylic acid solution in treatment of plane wart

Advanced Medical Journal
Background and objectives: Plane wart treatment is challenging; modalities such as cauterization and cryotherapy having a great probability to recur, as well as the risk of scarring, discomfort, and expensive costs.
Banu Muhammed Jaza Noori, Ali Mozan Dhahir Elethawi   +1 more
doaj   +1 more source

School-based educational and on-site vaccination intervention among adolescents: study protocol of a cluster randomised controlled trial [PDF]

, 2019
INTRODUCTION: Childhood vaccination programmes have been established in all Organisation for Economic Co-operation and Development (OECD) countries; however, measles, mumps and rubella (MMR) as well as diphtheria, tetanus, pertussis and polio (Tdap-IPV ...
Bethke, Norma, Gellert, Paul, Seybold, Joachim   +2 more
core   +1 more source

Measles Vaccination Before the Measles-Mumps-Rubella Vaccine

American Journal of Public Health, 2013
At the beginning of the 1960s, it was clear that a vaccine against measles would soon be available. Although measles was (and remains) a killer disease in the developing world, in the United States and Western Europe this was no longer so. Many parents and many medical practitioners considered measles an inevitable stage of a child’s development ...
Jan, Hendriks, Stuart, Blume
openaire   +3 more sources

Evaluation of a measles vaccine campaign by oral-fluid surveys in a rural Kenyan district: interpretation of antibody prevalence data using mixture models [PDF]

, 2009
We evaluated the effectiveness of a measles vaccine campaign in rural Kenya, based on oral-fluid surveys and mixture-modelling analysis. Specimens were collected from 886 children aged 9 months to 14 years pre-campaign and from a comparison sample of 598
A. BETT, A. VYSE, D. J. NOKES, D. SAMUEL, D. W. G. BROWN, E. A. OKIRO, E. O. OHUMA, Enquselassie, J. ABWAO, Kremer, N. GAY, Nokes, S. WERE, Vyse   +13 more
core   +2 more sources

A review of safety and immunogenicity of a novel measles, mumps, rubella (MMR) vaccine

Human Vaccines & Immunotherapeutics
Measles, mumps, and rubella (MMR) are highly infectious viral diseases affecting young children and have high secondary attack rates. Present MMR vaccines show consistent seroconversion rates for anti-measles and anti-rubella antibodies with variable ...
Nitin Shah, Apurba Ghosh, Kishore Kumar, Trayambak Dutta, Manish Mahajan   +4 more
doaj   +1 more source

Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients

mBio, 2020
The measles-mumps-rubella (MMR) vaccine has been theorized to provide protection against coronavirus disease 2019 (COVID-19). Our aim was to determine whether any MMR IgG titers are inversely correlated with severity in recovered COVID-19 patients ...
Jeffrey E. Gold, William H. Baumgartl, Ramazan A. Okyay, Warren E. Licht, Paul L. Fidel, Mairi C. Noverr, Larry P. Tilley, David J. Hurley, Balázs Rada, John W. Ashford   +9 more
doaj   +1 more source